| Kilitch Drugs (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524500 |
NSE Symbol : KILITCH |
P/E(TTM) : 24.70 |
|
ISIN Demat : INE729D01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 9.34 |
|
Book Value(₹) : 95.25 |
Market Cap(₹Cr) : 806.56 |
Face Value(₹) : 10.00 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|---|
| Gross Sales | 40.91 | 71.97 | 44.67 | 37.81 | 34.12 | 56.30 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 40.91 | 71.97 | 44.67 | 37.81 | 34.12 | 56.30 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 3.55 | 1.14 | 1.61 | 7.61 | 3.50 | 2.32 |
| Total Income | 44.46 | 73.11 | 46.28 | 45.42 | 37.62 | 58.63 |
| Total Expenditure | 36.27 | 52.50 | 38.95 | 34.14 | 30.55 | 42.40 |
| PBIDT | 8.19 | 20.61 | 7.33 | 11.28 | 7.07 | 16.23 |
| Interest | 0.49 | 0.58 | 0.60 | 0.68 | 0.59 | 0.72 |
| PBDT | 7.71 | 20.03 | 6.73 | 10.60 | 6.48 | 15.51 |
| Depreciation | 0.76 | 0.70 | 0.56 | 0.53 | 0.50 | 0.51 |
| Tax | 1.61 | 6.18 | 1.60 | 1.78 | 1.30 | 3.56 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.28 | -0.85 | -0.32 | -0.42 | -0.11 | 0.07 |
| Reported Profit After Tax | 5.05 | 14.00 | 4.89 | 8.72 | 4.79 | 11.37 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 5.05 | 14.00 | 4.89 | 8.72 | 4.79 | 11.37 |
| EPS (Unit Curr.) | 1.45 | 4.08 | 2.74 | 5.27 | 2.98 | 7.07 |
| EPS (Adj) (Unit Curr.) | 1.45 | 4.08 | 1.37 | 2.64 | 1.46 | 3.46 |
| Calculated EPS (Unit Curr.) | 1.45 | 4.00 | 2.80 | 4.99 | 2.98 | 7.07 |
| Calculated EPS (Adj) (Unit Curr.) | 1.45 | 4.00 | 1.40 | 2.50 | 1.46 | 3.46 |
| Calculated EPS (Ann.) (Unit Curr.) | 5.78 | 16.02 | 11.19 | 19.94 | 11.92 | 28.29 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 5.78 | 16.02 | 5.60 | 9.97 | 5.83 | 13.84 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 34.96 | 34.96 | 17.48 | 17.48 | 16.08 | 16.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 20.02 | 28.64 | 16.41 | 29.83 | 20.72 | 28.83 |
| PBDTM(%) | 18.85 | 27.83 | 15.07 | 28.03 | 18.99 | 27.55 |
| PATM(%) | 12.34 | 19.45 | 10.95 | 23.06 | 14.04 | 20.20 |
